| For: | Pitisuttithum P, Chan WK, Goh GBB, Fan JG, Song MJ, Charatcharoenwitthaya P, Duseja A, Dan YY, Imajo K, Nakajima A, Ho KY, Goh KL, Wong VWS, Treeprasertsuk S. Gamma-glutamyl transferase and cardiovascular risk in nonalcoholic fatty liver disease: The Gut and Obesity Asia initiative. World J Gastroenterol 2020; 26(19): 2416-2426 [PMID: 32476802 DOI: 10.3748/wjg.v26.i19.2416] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v26/i19/2416.htm |
| Number | Citing Articles |
| 1 |
Liling Wu, Man Zhang, Haofei Hu, Qijun Wan. Elevated gamma-glutamyl transferase has a non-linear association with incident non-alcoholic fatty liver disease in the non-obese Chinese population: a secondary retrospective study. Lipids in Health and Disease 2021; 20(1) doi: 10.1186/s12944-021-01577-8
|
| 2 |
Terry Cheuk-Fung Yip, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, George Boon-Bee Goh, Wah-Kheong Chan. Nonalcoholic Fatty Liver Disease. Medical Clinics of North America 2023; 107(3): 449 doi: 10.1016/j.mcna.2022.12.003
|
| 3 |
Liwei Ji, Xintian Cai, Yang Bai, Tao Li. Application of a Novel Prediction Model for Predicting 2-Year Risk of Non-Alcoholic Fatty Liver Disease in the Non-Obese Population with Normal Blood Lipid Levels: A Large Prospective Cohort Study from China. International Journal of General Medicine 2021; : 2909 doi: 10.2147/IJGM.S319759
|
| 4 |
Sebastian Lang, Philipp Wilhelm Sänger, Sandra Kocina, Christian von Loeffelholz. Hypoxia in A Patient with Anti-p200 Pemphigoid under Combined Dapsone and Pantoprazole Treatment. Biomedicines 2022; 10(11): 2837 doi: 10.3390/biomedicines10112837
|
| 5 |
Giovanni Targher, Kathleen E. Corey, Christopher D. Byrne. NAFLD, and cardiovascular and cardiac diseases: Factors influencing risk, prediction and treatment. Diabetes & Metabolism 2021; 47(2): 101215 doi: 10.1016/j.diabet.2020.101215
|
| 6 |
Xiaomin Hu, Ruilin Zhou, Hanyu Li, Xinyue Zhao, Yueshen Sun, Yue Fan, Shuyang Zhang. Alterations of Gut Microbiome and Serum Metabolome in Coronary Artery Disease Patients Complicated With Non-alcoholic Fatty Liver Disease Are Associated With Adverse Cardiovascular Outcomes. Frontiers in Cardiovascular Medicine 2022; 8 doi: 10.3389/fcvm.2021.805812
|
| 7 |
Kamran Mehrabani-Zeinabad, Awat Feizi, Masoumeh Sadeghi, Hamidreza Roohafza, Mohammad Talaei, Nizal Sarrafzadegan. Cardiovascular disease incidence prediction by machine learning and statistical techniques: a 16-year cohort study from eastern Mediterranean region. BMC Medical Informatics and Decision Making 2023; 23(1) doi: 10.1186/s12911-023-02169-5
|
| 8 |
Daniele Araujo de Azeredo Coutinho, Jenaine Rosa Godinho, Raphael Carreiro Moura, Rogério Martins Oliveira, Hevila Faria Passos, Jordana de Paula Felipe Mendes, Carlos Roberto Moraes de Andrade Junior, Luis Guillermo Coca-Velarde, Maria Auxiliadora Nogueira Saad, Priscila Pollo Flores, Debora Vieira Soares. Relationship between Liver Fibrosis Due to Metabolic Dysfunction-Associated Steatotic Liver Disease and Subclinical Atherosclerosis. Arquivos Brasileiros de Cardiologia 2025; 122(8) doi: 10.36660/abc.20240856i
|
| 9 |
Aizatul Shafiqah Mohd Faizal, T. Malathi Thevarajah, Sook Mei Khor, Siow-Wee Chang. A review of risk prediction models in cardiovascular disease: conventional approach vs. artificial intelligent approach. Computer Methods and Programs in Biomedicine 2021; 207: 106190 doi: 10.1016/j.cmpb.2021.106190
|
| 10 |
Daniele Araujo de Azeredo Coutinho, Jenaine Rosa Godinho, Raphael Carreiro Moura, Rogério Martins Oliveira, Hevila Faria Passos, Jordana de Paula Felipe Mendes, Carlos Roberto Moraes de Andrade Junior, Luis Guillermo Coca-Velarde, Maria Auxiliadora Nogueira Saad, Priscila Pollo Flores, Debora Vieira Soares. Relação entre Fibrose Hepática Decorrente da Doença Hepática Gordurosa Associada à Disfunção Metabólica e Aterosclerose Subclínica. Arquivos Brasileiros de Cardiologia 2025; 122(8) doi: 10.36660/abc.20240856
|
| 11 |
Panyavee Pitisuttithum, Sombat Treeprasertsuk. Nonalcoholic fatty liver disease (NAFLD) among older adults. Portal Hypertension & Cirrhosis 2022; 1(3): 184 doi: 10.1002/poh2.31
|
